Three scores SAVI close radiotherapy: reduce COVID - 19 patients during the interaction

This was a period of change of breast cancer treatment, neoadjuvant chemotherapy, no thread tumor location and other tools have made progress of postoperative radiotherapy.In the past two years, used to reduce the number of patients to the hospital the trichotomy of radiation therapy, or the XNUMX day close in radiotherapy TRIUMPH - T test, helped to redefine the mammary gland acceleration irradiation (APBI) implementation ways.

APBI always points 2 times a day, last XNUMX days.Close clinical benefit of radiation therapy targeted radiation include reducing radiation exposure to healthy tissue, improve the cosmetic effect and reduce the long-term side effects.

TRIUMPH - T test proved that the use of brachytherapy in just two days potential benefits for the treatment of patients.Test outlined some of the benefits include reduced to normal breast tissues and radiation, eliminate systemic/local treatment of delay and reduce the treatment time.At the same time maintain good cosmetic effect and local recurrence rate.

These benefits during the period of COVID - 19 more valuable, in this case, patients with limited contact and protect the PPE is becoming more and more important.

SAVI close radiotherapy in COVID - information graph of 19 minimize patient contact interaction

With using 16 integral large external beam radiotherapy (EBRT) segmentation, compared to 2 days of TRIUMPH - T in patients with a total of three interactive segmentation, it would significantly reduce the patients contact (to EBRT contact about a third).

Access to the original TRIUMPH - T test publications (In English)
Dr Charles Cox - university of Tampa, Florida - Merit Medical

Charles e. Cox, m.d., Ph.D., both FACS

Professors, a professor at the school of medicine, surgery
Is the Health, Tampa, Florida

"According to the report, the solution treatment in patients with excellent results combined with shorten schedule, make it become a more acceptable way, less contact to the patients and medical workers.During COVID - 19, as long as we can restrict contact without affecting the results or patients' satisfaction, we tend to do so.We welcome the simplified treatment of patients."

* reduced from 6 weeks fractionation schedules, not including promotion: the conservative estimates the number of interaction.

reference

  1. Khan, Atif, Peter j. y. Chen, Catheryn Yashar, Matthew m. Poppe, Linna Li, Zeinab Abou Mr Yehia and Frank a. Vicini, etc.Using "close radiotherapy applied in three grades accelerated partial breast irradiation (APBI) is feasible and safe: TRIUMPH - T test preliminary results".International journal of radiation oncology, biology, physics, 104, no.1 (2019) : 67-74.Doi: 10.1016 / j.i jrobp 2018.12.050.

Information by a medical doctor Catheryn m. Yashar and Dr Dan Scanderbeg provided.TRIUMPH - T APBI with SAVI.03 2020 March.La jolla, California.Webinar presentation archive at //www.narrowshealth.com/three-fraction-apbi-with-savi-webinar-apr-2020-XNUMX/.